A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

• Status: Withdrawn
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test how vinflunine interacts with rifampin in the human body

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Rifampin; Vinblastine

Criteria

Inclusion Criteria:

• Cancer unresponsive to previous treatment

• Consent for genetic samples

Exclusion Criteria:

• Cancer of the blood

• Spread of cancer to the brain

• Moderate or severe nerve damage

• Low white blood cell counts and platelet counts

• Inadequate liver or kidney function

• Prior treatment with vinflunine

• Use of certain medications that might interfere with the metabolism of vinflunine